BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

GENEWIZ, Inc. Announces European Expansion & Appointment of European Business Development Manager, Andre Kotze


10/6/2011 9:17:03 AM

SOUTH PLAINFIELD, NJ and LONDON--(Marketwire - October 06, 2011) - GENEWIZ, Inc., leading global provider of DNA services, announced European expansion with the launch of the GENEWIZ European Office in the United Kingdom. Andre Kotze, newly appointed European Business Development Manager, will lead GENEWIZ Europe operations.

"Expanding GENEWIZ operations into Europe is a direct result of the growing needs of the global scientific community," commented Shifang Zhang, Vice President of Corporate Development. "Having a local presence in the United Kingdom will increase accessibility, enabling GENEWIZ to offer enhanced, efficient local support and expertise, thus enriching the overall customer experience."

A leader in Sanger DNA sequencing services, GENEWIZ has quickly become a top provider of gene synthesis services, as well as molecular biology, genomic, and regulatory services. Committed to quality in all areas, GENEWIZ earned International Organization for Standardization (ISO) 9001:2008 Certification for Quality Management, a voluntary certification recognizing operational excellence and quality standards.

"Gene synthesis presents an efficient, cost-effective alternative for researchers currently performing molecular cloning," stated Kotze. "GENEWIZ's unique ability to codon-optimize sequences and design complex constructs, such as difficult templates, highly repetitive, AT-rich, and GC-rich DNA, allows us to meet all custom project requirements. In addition, fast and reliable delivery of 100% sequence-verified genes maintains customers' confidence when working with GENEWIZ."

"Marking significant growth for our global corporate development, the establishment of GENEWIZ Europe clearly demonstrates our commitment to the advancement of life sciences and the discovery of innovative solutions," remarked Zhang. "We are invigorated by this expansion and enthusiastic about what the future holds."

About GENEWIZ

GENEWIZ, Inc. is a global contract research organization (CRO) specializing in DNA-based services, including DNA sequencing, gene synthesis, molecular biology, genomic, and GLP/cGMP regulatory-compliant services. The company leads the industry in research sequencing and outsourcing partnerships with pharmaceutical, clinical, biotechnology, academic, and government institutions.

Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held, global enterprise with locations in Washington, D.C. Metro, Boston, San Diego, Beijing, China, Suzhou, China, and London, United Kingdom. For more information, please visit www.genewiz.com.


Andre Kotze
European Business Development Manager
Email Contact
T: +44 780 947 8030
www.genewiz.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES